Showing results (41-50 of 121) with videos related to
Sort By:
Pageof 13
Respiratory Investigation|January 13, 2018
Physical activity in daily life in patients with idiopathic pulmonary fibrosisOsamu Nishiyama, Ryo Yamazaki, Hiroyuki Sano, et al.Biochemistry and Biophysics Reports|September 6, 2021
The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophagesTakashi Matsuhira, Osamu Nishiyama, Yuji Tabata, et al.Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2016
Characteristics of phenotypes of elderly patients with asthmaHiroyuki Sano, Takashi Iwanaga, Osamu Nishiyama, et al.Respiratory Investigation|April 1, 2021
Real-world treatment and health care resource use among severe asthma patients in JapanYasuo To, Yurie Taguchi, Tatsuya Shimazaki, et al.Internal Medicine (Tokyo, Japan)|December 3, 2014
Cavitary pulmonary cryptococcosis with an Aspergillus fungus ballYasushi Makino, Osamu Nishiyama, Hiroyuki Sano, et al.European Journal of Pharmacology|April 4, 2016
Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db miceTakashi Nakamura, Takayo Murase, Mai Nampei, et al.Scientific Reports|February 17, 2021
Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosisRyo Yamazaki, Osamu Nishiyama, Kazuya Yoshikawa, et al.Respiratory Investigation|February 7, 2021
Clinical course and prognosis in survivors of acute exacerbations of idiopathic pulmonary fibrosisRyo Yamazaki, Osamu Nishiyama, Kazuya Yoshikawa, et al.Plos One|December 14, 2016
Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort StudyRyo Yamazaki, Osamu Nishiyama, Hiroyuki Sano, et al.Pharmaceutical Research|August 4, 2007
Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockersMasanobu Sato, Takashi Iwanaga, Hideaki Mamada, et al.Pageof 13